Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000318655 | SCV000335219 | uncertain significance | not provided | 2015-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000685876 | SCV000813376 | uncertain significance | Facioscapulohumeral muscular dystrophy 2 | 2022-08-07 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 283238). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with SMCHD1-related conditions. This variant is present in population databases (rs756368420, gnomAD 0.003%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1082 of the SMCHD1 protein (p.Asn1082Ser). |